Treatt PLC Board Change

RNS Number : 3286M

Treatt PLC

15 November 2024

 

 

 

15 November 2024

 

 

TREATT PLC

("Treatt" or "the Company")

 

 

Board Change

 

Treatt, the manufacturer and supplier of a diverse and sustainable portfolio of natural ingredients for the beverage, flavour and fragrance industries, announces that Dr. David Johnston, Non-Executive Director, has given notice of his intention to retire and step down from the Board after 14 years', following the Company's AGM on 30 January 2025.

 

Vijay Thakrar, Treatt's Chair, said "David has been a valued member of Treatt's Board since 2011 and has made a very significant contribution during his tenure.  By the time he steps down, David will have served as a Non-executive Director for 14 years in roles including Remuneration Committee Chair, Senior Independent Director and currently, chair of the Board's ESG Advisory Panel which, going forward, will be chaired by our CEO, David Shannon.  On behalf of the Board and all connected with the Company, I would like to thank David for his incredible dedication to Treatt. Like many others at the business, I have personally benefited hugely from David's industry insights and wise counsel. I'm pleased that, despite entering the retirement phase of his illustrious career, David has agreed to remain available to the Company for advice on industry matters after he steps down from the Board."

 

David commented "It's with a happy and crying eye that I leave Treatt. I'm looking forward to entering an exciting retirement but sad to leave Treatt and its wonderful employees. Under our current Board and leadership, I believe Treatt has a hugely successful future ahead of it".

 

 

 

 

For further information please contact:

 

Treatt plc                                                                                                            

 

Abby Burton-Hopkins

Assistant Company Secretary

 

01284 702500

END

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

BOAQKQBKOBDDODD